· Learning Objective 1: Define success with use of second-line overactive bladder treatments

· Learning Objective 2: Identify candidates for third-line overactive bladder treaments

· Learning Objective 3: Understand the mechanism and efficacy of third-line overactive bladder treatments

Session date: 
02/28/2018 - 8:00am to 9:00am CST
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Adam Gafni-Kane, MD